FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA) since 2004. Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Ajovy (fremanezumab-vfrm) - September 14, 2018
- Lumoxiti (moxetumomab pasudotox-tdfk) - September 13, 2018
- Xelpros (latanoprost) - September 12, 2018
- Cassipa (buprenorphine and naloxone) - September 07, 2018
- Tiglutik (riluzole) - September 05, 2018
- Delstrigo (doravirine, lamivudine and tenofovir disoproxil fumarate) - August 30, 2018
- Jivi (antihemophilic factor [recombinant] PEGylated-aucl) - August 30, 2018
- Pifeltro (doravirine) - August 30, 2018
- Xerava (eravacycline) - August 27, 2018
- Altreno (tretinoin) - August 23, 2018
- Takhzyro (lanadelumab-flyo) - August 23, 2018
- Inveltys (loteprednol etabonate) - August 22, 2018
- Oxervate (cenegermin-bkbj) - August 22, 2018
- Diacomit (stiripentol) - August 20, 2018
- Cequa (cyclosporine) - August 14, 2018
- Annovera (ethinyl estradiol and segesterone acetate) - August 10, 2018
- Galafold (migalastat) - August 10, 2018
- Onpattro (patisiran) - August 10, 2018
- Arakoda (tafenoquine) - August 08, 2018
- Jornay PM (methylphenidate hydrochloride) - August 08, 2018
